Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $258.23. The company's market cap stands at 622.22B, with a P/E ratio of 29.44 and a dividend yield of 2.06%.
On 2026-06-30, Johnson & Johnson(JNJ) stock opened at $252.07, reached a high of —, and a low of —.
Johnson & Johnson(JNJ) shares are trading with a volume of 0, against a daily average of 10.65M.
During the past year, Johnson & Johnson(JNJ) stock moved between $151.52 at its lowest and $258.58 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $151.52 at its lowest and $258.58 at its peak.
JNJ News
Johnson & Johnson (JNJ) is back in focus after the European Medicines Agency’s committee backed expanded use of its cancer drug Tecvayli with Darzalex, alongsid...
...
Why Today’s Retirees May Need More Stocks Than Their Parents Did By Drew Wood Published Jun 28, 7:11AM EDT Quick Read Modern retirements stretch 25 to 35 year...
Analyst ratings
69%
of 26 ratingsMore JNJ News
If you are wondering whether Johnson & Johnson stock still offers value after a strong run, this article breaks down what the current price might be implying ab...
Key Points Guggenheim analyst Vamil Divan raised his price target on Johnson & Johnson stock today. Upside is perhaps only 12% over the next year, however. 1...
Johnson & Johnson announced new data across 12 abstracts at the European Academy of Neurology 2026 Congress that offer additional insight into the use of IMAAVY...
Key Points Bristol Myers Squibb maintains a robust biopharmaceutical portfolio focused on high-stakes oncology and immunology treatments. Johnson & Johnson le...
Dividend Safety Check: VIG and the Dividend Appreciation Approach By John Seetoo Published Jun 26, 10:00AM EDT Vanguard Dividend Appreciation ETF (VIG) — larg...
The Portfolio That Quietly Pays Your Property Taxes Forever By Drew Wood Published Jun 26, 9:43AM EDT Quick Read Covering a $6,000 annual property tax bill re...
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $270 from $266 and keeps a Buy rating on the shares ahead of the company k...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.